Mammalian Hsf1 activator and inhibitor have demonstrated efficacy in the treatment of mammalian ailments, such as neurological disorders and malignancies (Neef et al., 2011; Neef et al., 2014; Dong et al., 2020). Here, HSF1 is linked to nervous system disorder.